ema glp-1 vision loss recommendation ophthalmology november 2025 A study in JAMA Network Open adds to the growing evidence connecting GLP1 receptor agonist drugs with diabetic retinopathy. In people with type 2 diabetes, the study found a 7% increased risk Vision loss risks in patients

doi: 10.3390/molecules25010182

Carbohydrate ingestion augments L-carnitine retention in humans

I.CidlowskiJ

Evidence that you used a brand name GLP-1 medication This can be in the form of prescriptions, packaging with the prescription label in your name, or medical records showing that a doctor prescribed you one of these brand name medications: Ozempic, Trulicity, Wegovy, Mounjaro or Rybelsus

Response of the glutathione (GSH) antioxidant defense system to oxidative injury in necrotizing enterocolitis Alena

Article 8 mins How to Build a Talent Strategy for the Future Creating the right mix of talent will be key for capturing (re)insurance growth opportunities as transformative trends shape the future landscape